Pharmos(PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Zvi Steinberg who wrote (593)	4/16/1998 2:10:00 AM
From: Stephen D. Wilson	Read Replies (3) of 1491

Zvi, Will you please forward this to Mr Aviv. Mr Aviv, I for one, as a shareholder, would like to thank you for responding to the readers on this board. It was uplifting to see the CEO of a company take the time to address us in the manner in which you did. As a long time user of these boards I don't think I can ever recall a CEO addressing the shareholders that way. I have been a long time shareholder and have had faith in your Company. I must admit though it hasn't always been easy to sit by and watch the rest of Wall Street hit record profits. Best of luck with HU-211. Not only do I see it as potentially profitable for the stockholders but beneficial to human kind. As a person who works in Field Emergency Medicine I have too often seen the devastating after-effects of head trauma. If this drug is able to sufficiently reduce the post trauma ICP to the point where many of the debilitating effects are reduced then my hat is off to you and your research team. Again, thank you, Steve Wilson

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next